When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NTGN - Neon to start cell therapy trial in Europe; shares up 3% premarket
Neon Therapeutics Inc.
Neon Therapeutics (NASDAQ:NTGN) has filed a Clinical Trial Authorization (CTA) with the Dutch Health Authority for the evaluation of NEO-PTC-01 in patients with metastatic melanoma who are refractory to checkpoint inhibitors.
More news on: Neon Therapeutics, Inc., Healthcare stocks news, Stocks on the move,